PPCB vs VICI · P/E 0.0, $3.9M cap vs P/E 9.3, rev $3.85B
Propanc Biopharma, Inc. Common Stock (PPCB) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
PPCB does not have a complete income-statement cache yet.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the PPCB and VICI stock pages for the full models.
Not investment advice.